Kevin Stankiewicz

The “Mad Money” host said everybody besides institutional money managers get “the short end of the stick” in SPAC deals.

CNBC’s Jim Cramer offered a list of 12 stocks investors should put on their radar for when the “indiscriminate selling” of newly public companies stops.

“I’m focused on doing exactly the opposite and exploring how much price elasticity there is for the business,” Peloton CEO Barry McCarthy told Jim Cramer.

“We’re working with our international aid agencies to ensure there’s some humanitarian aid,” Council of Economic Advisers Chair Cecilia Rouse told CNBC.

The Club thinks Disney is a buy, as shares trade in the red following its second-quarter earnings release the prior evening.

RBC Capital Markets analysts upgraded Danaher, touting the life-sciences firm as the kind of high-quality, defensive stock to own right now.

The Investing Club breaks down CNBC’s interview with Costco CEO Craig Jelinek.

We don’t own Eli Lilly exclusively for its potential Alzheimer’s treatment. However, we still find Biogen’s topline data to be very encouraging for Lilly.

Morgan Stanley’s diversification strategy is paying off, CEO James Gorman said Thursday, even if that’s not reflected in the bank’s stock price just yet.

The CEO of Eli Lilly (LLY) pinned the company’s outlook revision on the strong dollar. “The underlying fundamentals of the business are really strong.”